Bayer has discontinued an early-stage clinical gene therapy for a rare genetic disorder in favor of a similar candidate.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
Bayer has discontinued an early-stage clinical gene therapy for a rare genetic disorder in favor of a similar candidate.